氩气等离子凝固与电刀封闭肝断面在肝细胞癌根治性切除中的预后与复发模式比较
该回顾性研究纳入2013至2020年间586例接受根治性肝切除的肝细胞癌患者,比较氩气等离子凝固(APC)与电刀(EK)封闭肝断面的预后差异。经1:1倾向评分匹配后分析237对患者,发现APC与显著改善的无复发生存期(RFS)相关(HR=1.375,95%CI 1.041-1.816,P=0.023),且明显减少手术切缘复发(P<0.001),但总生存期(OS)差异未达统计学显著性(HR=1.639,95%CI 0.965-2.782,P=0.064)。
要点
- APC封闭肝断面可显著改善肝细胞癌根治术后的无复发生存期。
- APC明显减少手术切缘复发,是RFS的独立保护因素。
- 肝功能储备良好(ALBI 1级)患者可能从APC获得额外OS获益。
核心结论
- 肝断面使用APC与肝细胞癌根治性切除后更好的复发控制相关,主要通过减少手术切缘复发实现。
- 部分肝功能储备良好的患者可能获得额外生存获益。
研究设计与样本
- 回顾性分析2013至2020年间586例接受根治性肝切除的肝细胞癌患者。
- 按肝断面封闭技术分为APC组和EK组,采用1:1倾向评分匹配平衡基线特征。
- 匹配后237对患者纳入分析,使用Kaplan-Meier法和Cox比例风险模型评估生存与复发。
主要发现
- 匹配后APC组RFS显著优于EK组(HR=1.375,95%CI 1.041-1.816,P=0.023)。
- OS差异未达统计学显著性(HR=1.639,95%CI 0.965-2.782,P=0.064)。
- 多因素分析证实APC是RFS的独立保护因素。
- APC在匹配前后均显著减少手术切缘复发(P<0.001)。
- 亚组分析显示多数分层中RFS获益一致,ALBI 1级患者OS获益更明显。
临床怎么用
- 在肝细胞癌根治性肝切除中,可考虑使用APC封闭肝断面以降低切缘复发风险。
- 对于肝功能储备良好(ALBI 1级)的患者,APC可能带来额外生存获益。
局限性
- 回顾性研究设计可能存在选择偏倚。
- OS差异未达统计学显著性,需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative recurrence remains a major challenge after curative hepatectomy for hepatocellular carcinoma (HCC). While surgical margin width and resection strategies have been extensively studied, the oncological impact of liver transection sealing techniques has received limited attention. This study compared argon plasma coagulation (APC) and electrosurgical knife (EK) in sealing the liver transection surface during curative resection for HCC. METHODS: A total of 586 patients who underwent curative hepatectomy for HCC between 2013 and 2020 were retrospectively analyzed. Patients were classified into the APC and EK groups according to the liver transection sealing technique used. To balance baseline characteristics, 1:1 propensity score matching (PSM) was applied. Kaplan-Meier analysis was used to evaluate overall survival (OS), recurrence-free survival (RFS), and recurrence patterns, while Cox proportional hazards models with robust variance estimation were employed for statistical analysis. Sensitivity analyses were conducted to assess the robustness of the findings. Prespecified subgroup analyses were conducted to explore potential effect modifiers. RESULTS: After matching, 237 patient pairs with balanced covariates were analyzed. APC was associated with significantly improved RFS compared with EK (HR = 1.375, 95% CI 1.041-1.816, P = 0.023), while the OS difference did not reach statistical significance (HR = 1.639, 95% CI 0.965-2.782, P = 0.064). Multivariate analysis confirmed APC as an independent protective factor for RFS. APC markedly reduced surgical margin recurrence both before and after matching (P < 0.001). Subgroup analyses showed consistent RFS benefit across most strata, with suggesting greater OS benefit in patients with preserved hepatic function (ALBI grade 1). CONCLUSION: APC use during liver transection is associated with improved recurrence control after curative hepatectomy for HCC, primarily through reducing surgical margin recurrence. Selected patients with preserved hepatic reserve may derive additional survival benefit.
引用
- Ye T, Yu R, Lin D, et al. Comparing argon plasma coagulation and electrosurgical knife in sealing liver transection for hepatocellular carcinoma: prognosis and recurrence patterns. Surg Endosc. 2026. PMID: 42257958. doi:10.1007/s00464-026-12754-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。